Community-based, interventionist-guided weight loss program was efficacious for early-stage survivors.
Family history does not predict aggressiveness of prostate cancer or suitability for active surveillance as a treatment option.
A report on incidence of thyroid cancer shows incidence of the disease is increasing among certain populations: younger persons, Hispanic, and African American.
Although median survival is longer for Hispanic and black patients compared with white patients, health-related QoL is poor for minority patients.
NCI awarded a $9 million grant to Barbara A. Karmanos Cancer Institute and Wayne State University to explore factors contributing to racial disparities in cancer.
African American men choosing active surveillance for their low-grade prostate cancer have overall poorer health than non-African American men undergoing active surveillance.
Administering chemotherapy to African-American women with breast cancer prior to surgery may help improve their survival.
Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino WomenDecember 09, 2016
A community breast navigation program successfully increased mammogram screening rates among African American and Latino women, according to a study presented at the 2016 San Antonio Breast Cancer Symposium (SABCS).
A new tool may show promise for improving clinical trial participation among black women with breast cancer, according to a study presented at the 2016 San Antonio Breast Cancer Symposium (SABCS).
African American survivors of breast cancer experience significant problem burden during the first 5 years after diagnosis and treatment.
Risk of ovarian cancer is higher in African American women with lower socioeconomic status, the opposite of trends seen in breast cancer.
Use of androgen suppression therapy may negatively impact survival in African American patients with favorable-risk prostate cancer.
Excess abdominal fat in overweight and obese women could interfere with detection of early symptoms of ovarian cancer, and this may contribute to the higher risk of death from ovarian cancer in African American women compared with white women.
Several genetic differences uncovered in an analysis of data from The Cancer Genome Atlas (TCGA) are biologically plausible contributing factors for the worse survival of African American patients with clear cell renal carcinoma, even in the era of targeted therapy.
Lung Cancer Screening Criteria Need to Recognize Differences in Smoking Patterns of African AmericansApril 08, 2016
Screening for lung cancer may have a disparity between African Americans and whites due to differences in smoking habits.
Disparities in some cancer mortality rates between African Americans and whites in the United States have decreased, but these differences remain in colorectal and breast cancers.
African-American pediatric patients with Hodgkin lymphoma still display a considerable survival disparity when compared to their white and Hispanic peers.
African American men with Gleason score 3+3=6 prostate cancer produce less PSA and have significantly lower PSA density than white men, according to a new study. These findings could have important implications for treatment decision-making.
Black women with breast cancer treated with early chemotherapy fare worse than women of other minority groups.
Older black men with localized prostate cancer were more likely to have poorer quality care, incur higher costs, and have worse postoperative outcomes than white men. However, that did not translate to worse overall or cancer-specific survival.
Young black women with a breast cancer diagnosis at age 50 years or younger have a much higher BRCA mutation frequency than that previously reported among young white women with breast cancer.
An algorithm dubbed ENVE can help clinicians sort through "white noise" and pinpoint genetic aberrations associated with cancer.
African American men are more likely to develop prostate cancer than European American men, and are also more than twice as likely to die from it.
A new noninvasive technology for colon cancer screening could prove promising for African-Americans, a group at higher than average risk of colon cancer.
A new study reveals specific genetic alterations that appear to impact the prognosis and survival rates of African American women.
Although racial disparities for cancer are decreasing, cancer mortality among African Americans as a group remains elevated.
Survival mechanism in breast cancer cells is found to result in poorer outcomes for African American womenMay 06, 2015
The worse outcomes for African American women with estrogen-receptor positive (ER+) breast cancer, when compared with European American patients, appears to be related to a reduced cellular sensitivity to tamoxifen.
Depressed African American patients with cancer could be more accurately identified if the depression measures used are more culturally sensitive, according to a study.
Newly discovered segments of DNA shared by African American family members who have breast cancer indicate there may still be undiscovered breast cancer genes that may be unique to African Americans.
A new risk prediction model will allow for greater accuracy in predicting risk for breast cancer in African American women.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|